Zymeworks Inc.
ZYME
$14.81
-$0.03-0.20%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 122.87M | 93.38M | 76.30M | 62.20M | 62.71M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 122.87M | 93.38M | 76.30M | 62.20M | 62.71M |
Cost of Revenue | 143.60M | 139.50M | 136.50M | 124.66M | 121.08M |
Gross Profit | -20.74M | -46.11M | -60.20M | -62.46M | -58.38M |
SG&A Expenses | 61.97M | 62.70M | 61.51M | 60.14M | 63.26M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 205.58M | 202.20M | 198.01M | 184.81M | 184.34M |
Operating Income | -82.71M | -108.81M | -121.70M | -122.61M | -121.64M |
Income Before Tax | -67.42M | -107.17M | -116.61M | -118.02M | -115.98M |
Income Tax Expenses | 6.25M | 6.51M | 6.08M | -4.35M | -3.47M |
Earnings from Continuing Operations | -73.68 | -113.68 | -122.70 | -113.67 | -112.51 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -73.68M | -113.68M | -122.70M | -113.67M | -112.51M |
EBIT | -82.71M | -108.81M | -121.70M | -122.61M | -121.64M |
EBITDA | -72.61M | -99.29M | -113.02M | -114.71M | -112.69M |
EPS Basic | -0.98 | -1.50 | -1.62 | -1.51 | -1.52 |
Normalized Basic EPS | -0.56 | -0.75 | -0.83 | -0.85 | -0.85 |
EPS Diluted | -0.98 | -1.50 | -1.62 | -1.51 | -1.53 |
Normalized Diluted EPS | -0.56 | -0.75 | -0.83 | -0.85 | -0.85 |
Average Basic Shares Outstanding | 301.30M | 302.35M | 303.40M | 299.57M | 294.01M |
Average Diluted Shares Outstanding | 303.48M | 302.50M | 303.52M | 299.63M | 294.05M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |